Rapamycin Holdings' Seed VC Round

Rapamycin Holdings raised a round of funding on February 03, 2014. Investors include UT Horizon Fund.

Rapamycin Holdings licenses rapamycin-related intellectual property developed at the UTHSCSA. Rapamycin, a drug federally approved to suppress organ rejection, continues to be studied for its potentia…

Articles about Rapamycin Holdings' Seed VC Round: